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Abstract: Background: Nut consumption has been associated with improved nutrient adequacy and
diet quality in healthy adult populations but this association has never been explored in individuals
at high cardiovascular risk. Objective: to assess the associations between consumption of nuts and
nutrient adequacy and diet quality in a Mediterranean population at high cardiovascular risk. Design:
baseline assessment of nutritional adequacy in participants (n = 6060, men and women, with ages
55–75 years old, with overweight/obesity and metabolic syndrome) in the PREDIMED-PLUS primary
cardiovascular prevention randomized trial. Methods: nut intake was assessed using a validated
food frequency questionnaire. Participants who reported consuming zero quantity of nuts were
classified as ‘non-nut consumers’. ‘Nut consumers’ were participants who reported consuming any
quantity of nuts. Nineteen micronutrients were examined (vitamins B1, B2, B3, B6, B12, A, C, D, E and
folic acid; Ca, K, P, Mg, Fe, Se, Cr, Zn, and iodine). The proportion of micronutrient inadequacy was
estimated using the estimated average requirements (EAR) or adequate intake (AI) cut-points. Diet
quality was also assessed using a 17-item Mediterranean dietary questionnaire (Mediterranean diet
score, MDS), a carbohydrate quality index (CQI) and a fat quality index (FQI). Results: eighty-two
percent of participants were nut consumers (median of nut consumption 12.6 g/day; interquartile
range: 6.0–25.2). Nut consumers were less likely to be below the EAR for vitamins A, B1, B2, B6, C, D,
E, folic acid, and Ca, Mg, Se and Zn than non-nut consumers. Nut consumers were also more likely
to be above the AI for K and Cr than non-nut consumers. Nut consumers had lower prevalence of
inadequate micronutrient intakes, but also higher CQI, higher FQI, and better scores of adherence
to the Mediterranean diet (Mediterranean diet score, MDS). Conclusions: nut consumers had better
nutrient adequacy, diet quality, and adherence to the MedDiet than those non-nut consumers.
Keywords: nut consumption; nutrient adequacy; diet quality; Mediterranean diet; cardiovascular
risk disease
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1. Introduction
The Mediterranean diet (MedDiet) is a pattern with high nutritional quality. It has been
demonstrated that higher levels of adherence to a Mediterranean dietary pattern are associated
with a reduced risk of inadequate nutrient intake [1,2]. Recently, nut consumption (i.e., peanuts,
almonds, hazelnuts, walnuts, pine nuts, pistachios, Brazil nuts, macadamia and cashews), a key food
of the MedDiet, has been reported to be associated with an improvement in nutrient intakes but also
with better overall nutrient adequacy and diet quality in adult populations [3–6]. In particular, in the
National Health and Nutrition Examination Survey (NHANES) 1999–2004 data, the diets of tree nut
consumers contained greater amounts of dietary fiber, vitamin E, Ca, Mg and K and lower amounts of
Na compared to non-consumers [3]. In addition, in the NHANES 2005–2010, using the Healthy Eating
Index-2005, diet quality was found to be higher in nut consumers [6]. In the New Zealand Adult
Nutrition Survey (NZANS) 2008/09 data, the diets of whole nut consumers contained greater energy
and percentage of energy total fat, monounsaturated fatty acids (MUFA) and polyunsaturated fatty
acids (PUFA), and greater amounts of dietary fiber, vitamin E, folate, Cu, Mg, K, P and Zn, whereas
energy from saturated fatty acid (SFA) and carbohydrate, and intakes of cholesterol and vitamin B12
were significantly lower compared with non-whole nut consumers [6].
Nuts have high contentof MUFA and PUFA, soluble fiber, vitamins (e.g., folate and vitamin E),
minerals (e.g., Ca, Mg, Cu, Zn, Se and K) and bioactive compounds (e.g., phytosterols, antioxidants
and phenolic compounds), which independently or jointly confer health benefits, and frequent
consumption was associated to a lower risk of all-cause and cause-specific mortality, with the strongest
reduction for coronary heart disease mortality [7]. Frequent nut consumption could play a role
in reducing the risk of cardiovascular risk disease [8–11]. However, a limited number of studies
have examined associations between nut consumption and nutrient intakes or diet quality [3–6].
None have investigated these associations in a Mediterranean population at high cardiovascular risk.
Our hypothesis is that consumption of nuts is going to increase nutrient adequacy, diet quality and
adherence to Mediterranean diet. Then, our aim was to assess the associations between consumption of
nuts and nutrient adequacy and diet quality in a Mediterranean population at high cardiovascular risk.
2. Materials and Methods
2.1. Study Design
The present study was a cross-sectional analysis on baseline data within the frame of the
PREDIMED-PLUS study, a six-year multicentre, parallel-group, randomised trial conducted in
Spain to assess the effect on cardiovascular disease morbimortality of an intensive weight loss
intervention programme based on an energy-restricted traditional MedDiet (erMedDiet), physical
activity promotion and behavioural support, in comparison with an usual care intervention only
with energy-unrestricted MedDiet (control group). Details on the study protocol can be found
elsewhere [12] and at http://predimedplus.com/. The trial was registered in 2014 at the International
Standard Randomized Controlled Trial (ISRCT; http://www.isrctn.com/ISRCTN89898870) with
number 89898870.
2.2. Participants, Recruitment and Randomization
Eligible participants were community-dwelling adults (aged 55–75 in men; 60–75 in women),
who were overweight or obese (body mass index (BMI) ≥ 27 and <40 kg/m2) and met at least
three criteria for the metabolic syndrome (MetS) according to the updated harmonized criteria of the
International Diabetes Federation and the American Heart Association and National Heart, Lung and
Blood Institute [13].
From 5 September 2013 to 31 October 2016, a total of 6874 participants were recruited in 23 Spanish
centres (universities, hospitals and research institutes).
Nutrients 2019, 11, 754 4 of 17
All participants provided written informed consent, and the study protocol and procedures
were approved according to the ethical standards of the Declaration of Helsinki by all the
participating institutions.
2.3. Dietary Assessment
Registered dietitians collected data on dietary intake at baseline with a semiquantitative 137-item
food frequency questionnaire (FFQ), repeatedly validated in Spain [14]. Detailed information about
the development, reproducibility and validity of FFQ in the PREDIMED cohort has been previously
reported [15,16]. For each item, a typical portion size was included and consumption frequencies were
registered in nine categories that ranged from “never or almost never” to “≥6 times/day”. Energy
and nutrient intakes were calculated as frequency multiplied by nutrient composition of specified
portion size for each food item, using a computer program based on available information in Spanish
food composition tables [17–19]. We also considered for the total nutrient intake the average intake of
micronutrients from dietary supplements, declared by participants in the FFQ. Participants reporting
extreme total energy intakes (<500 or >3.500 kcal/day in women or <800 or >4.000 kcal/day in men)
or outliers for micronutrient intake (at three or more standard deviations (SD) from both sides of the
mean) were excluded from the analysis [2]. The final sample in the present study included 6060 subjects
(3118 men and 2942 women) who had available data on nutrient intake.
2.4. Determination of Nut Consumption
For the purpose of this study, nut consumption was assessed using the FFQ data, and total nut
consumption comprised of the following four categories: almonds, pistachios, walnuts, and other nuts.
Participants who reported consuming zero quantity of nuts in their FFQ were classified as ‘non-nut
consumers’ (n = 1091), and ‘nut-consumers’ (n = 4969) were participants who reported consuming
any quantity of nuts. ‘Nut-consumers’ were also categorized into quintiles (Q1: <4.2 g/day, n = 911;
Q2: 4.2–8.3 g/day, n = 1058; Q3: 8.4–14.5 g/day, n = 868; Q4: 14.6–29.3, n = 1093; Q5: ≥29.4 g/day,
n = 1039).
2.5. Determination of Micronutrients Intake
The micronutrients examined were vitamins B1, B2, B3, B6, B12, C, A, D, E and folic acid, and Zn,
iodine, Se, Fe, Ca, K, P, Mg, and Cr. We used the dietary references intakes (DRIs) values proposed by
Institute of Medicine [17], that are quantitative estimates of nutrient intakes to be used for assessing and
planning diets for healthy people and included four different values: estimated average requirements
(EAR), recommended daily allowances (RDA), adequate intake (AI) (i.e., values for nutrients having
undetermined RDA), and tolerable upper level (UL) values. We estimated the prevalence of inadequate
micronutrients intake according to sex and age by using the EAR cut-point, except for K and Cr intakes,
whose prevalence was evaluated based on AI cut-point [18,19].
The carbohydrate (CHO) quality index (CQI) and the fat quality index (FQI) were calculated as
previously described [2,20]. Briefly, the CQI was defined summing up quintiles of the following four
criteria: dietary fiber intake (g per day, positively weighted), glycemic index (negatively weighted),
ratio whole grains/total grains (positively weighted), and finally, ratio solid CHO/(solid CHO + liquid
CHO) (positively weighted). Solid CHO intake included all CHO containing solid foods, and liquid
CHO intake included sugar-sweetened beverages and fruit juice. For each of these four components,
we categorized participants into quintiles and received a value (ranging from one to five) according
to each quintile (for GI, those in the fifth quintile received one point and those in the first quintile
received five points). Finally, we constructed the CQI summing all values. All criteria had the same
weighting, and the CQI ranged from four to 20. On the other hand, the FQI was calculated using the
ratio (MUFA + PUFA)/(SFA + trans fatty acid [TFA]) as a continuous variable.
Registered dietitians also administered a 17-item Mediterranean dietary questionnaire, a modified
version of the previously validated questionnaire used in the PREDIMED trial [21], designed to
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assess adherence to the Mediterranean diet. Compliance with each of the 17 food habits reflecting
a Mediterranean diet was scored with one point, and zero points otherwise. Therefore, a score
ranging from 0–17 points, with 0 meaning no adherence and 17 meaning maximum adherence to the
Mediterranean diet (Mediterranean diet score (MDS)) was developed.
2.6. Physical Activity
Physical activity was measured using the validated Minnesota-REGICOR short physical activity
questionnaire [22–24] and the validated Spanish version of the nurses’ health study questionnaire to
assess sedentary behaviours [25]. In dietary assessment according to physical activity variables,
participants who had not responded to all of the physical activity questionnaires (n = 14) and
participants reporting outliers for total physical activity expressed as MET·min/week (at three or more
SD from the mean for each sex) were excluded and 5742 participants were included in the analysis
(2981 men and 2761 women).
2.7. Anthropometric and Blood Pressure Measurements
Anthropometric variables were measured by trained personnel according to the PREDIMED-PLUS
protocol. Weight and height were measured with high-quality electronic calibrated scales and a
wall-mounted stadiometer, respectively. The body mass index was calculated as weight in kilograms
divided by the square of height in meters. Waist circumference was measured halfway between the
last rib and the iliac crest by using an anthropometric tape. Blood pressure was measured in triplicate
with a validated semi-automatic oscillometer (Omron HEM-705CP, the Netherlands) after five minutes
of rest in-between measurements while the participant was in a seated position. All anthropometric
variables were determined in duplicate, except for blood pressure (in triplicate).
2.8. Blood Collection and Analysis
Blood samples were collected after an overnight fast and biochemical analyses were performed on
fasting plasma glucose, total cholesterol, high density lipoprotein (HDL)-cholesterol and triglyceride
concentrations in local laboratories using standard enzymatic methods.
2.9. Other Health Variables
Information related to individual medical history, current medication use and smoking status
were also obtained.
2.10. Statistical Analyses
Analyses were performed with the SPSS statistical software package version 25.0 (SPSS Inc.,
Chicago, IL, USA). Data are shown as mean, standard deviation (SD) or, median and interquartile
range (IQR). Difference in means between the two comparison groups were tested by an unpaired
Students’ t-test. Differences in means between the quintiles of nut consumption were tested by one-way
ANOVA with Bonferroni post-hoc test. The difference in prevalence across nut consumers and non-nut
consumers was examined using χ2 (all p values are two-tailed). We have also defined the cut-off
≥6 and ≥8 unmet DRI according to the number of nutrients unmet. Thus, six and eight unmet DRI
of all nutrients examined as previously described. Logistic regression analyses with the calculation
of corresponding odds ratio (OR) and the 95% confidence interval (95% CI) were used to examine
the association between unmet DRI in ≥6 or ≥8 items (dependent variables) and nut consumption
(independent variable). Univariate analysis was first carried out for the two different cut-offs (crude
OR). Secondly, results were adjusted for sex, energy intake (continuous variable) and physical activity
(continuous variable, expressed as MET·min/week) to control for potential confounding. Thirdly,
results were adjusted for sex, energy intake (continuous variable), total fat intake (continuous variable,
expressed as % of total energy intake), MDS (continuous variable) and physical activity (continuous
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variable, expressed as MET·min/week). Results were considered statistically significant if p-value
(two-tailed) <0.05.
3. Results
Overall, 82.0% of participants were nut consumers (83.6% of men and 80.3% of women, p = 0.001);
the median of nut consumption was 12.6 g/day (IQR: 6.0, 25.2). Table 1 shows the comparison of diet
quality and lifestyle characteristics between the two study groups. Nut consumers had higher intakes
of energy, solid CHO, total fat, PUFA, MUFA, cholesterol and fibre intake, but lower intakes of total
CHO than non-nut consumers. No statistically significant differences were found in intakes of liquid
CHO, SFA and TFA. Usual intake of fruits, vegetables, legumes, olive oil, total fish and total meat were
all higher in nut consumers compared with non-nut consumers. Nut consumers had also lower usual
intake of dairy products than non-nut consumers. No statistically significant differences were found in
usual intake of total cereals, cookies and alcohol between the two comparison groups. Nut consumers
had lower glycaemic index and higher CQI and FQI than non-nut consumers. They also had a higher
MDS (even when nuts were not included in the MDS: 7.7 ± 2.6 g/day for non-nut consumers and
8.1 ± 2.5 g/day for not consumers, p < 0.001; data not shown). On the other hand, nut consumers
had lower BMI and reported higher total physical activity (expressed as MET·min/week). Statistically
significant differences in smoking habit were also found between the two nut groups. Finally, no
statistically significant differences in MetS components were found between the two groups.
Table 2 shows usual intake of vitamins and minerals. Nut consumers had higher intakes of all
vitamins (B1, B2, B3, B6, B12, C, A, D, E and folic acid) and minerals (Zn, Se, Fe, Ca, K, P, Mg, and Cr)
examined in the present study, except for iodine. Table 2 also shows that nut consumers were less
likely to be below the EAR for vitamins A, B1, B2, B6, C, D, E and folic acid, Ca, Mg, Se and Zn than
non-nut consumers. Furthermore, results showed a percent below the EAR equal or below 10% for
vitamins B1, B2, B3, B6, B12 and C, and P, Fe, Se, Zn and iodine (only in nut consumers); a prevalence
between 11 and 20% for vitamin A and Mg in nut consumers, and for iodine in non-nut consumers; a
prevalence above 21% for vitamin D, vitamin E, folic acid and Ca in both groups, and for vitamin A
and Mg in non-nut consumers. Nut consumers were also more likely to be above the AI for K and Cr
than non-nut consumers. No statistically significant differences in vitamin B3, vitamin B12, P or Fe
were found between the two groups.
Usual intake of vitamins and minerals of the nut consumers as per quintiles of nut consumption
were also assessed (Table 3). Intakes of all vitamins and minerals (except for iodine) increased when
increased quintiles of nut consumption. Participants in the highest quintile of nut consumption were
less likely to be below the EAR for vitamins A, B1, B2, B6, C, D, E and folic acid, Ca, Mg, and Zn.
Participants in the highest quintile of nut consumption were also more likely to be above the AI for K
and Cr. No statistically significant differences in vitamins B3 and B12, P, Fe, Se and iodine were found
between the quintiles of nut consumption.
Finally, the average number of nutrients for which the DRIs were unmet was 4.4 (SD: 1.7) in
nut-consumers and 5.2 (SD: 2.0) in non-nut consumers (p < 0.001) (difference = 0.9, 95% CI: 0.7, 1.0).
Moreover, the average number of nutrients for which the DRIs were unmet was also lower for
participants in the fifth quintile (Q5, n = 1039) of nut consumption (3.6, SD: 1.3) than for participants
in the first quintile (Q1, n = 911) of nut consumption (5.0, SD: 1.9) (difference = 1.4, 95% CI: 1.2, 1.5)
(Figure 1). Nut consumers were also less likely to have unmet DRI ≥6 and ≥8 than non-nut consumers
in crude and multivariable-adjusted analyses (except for DRI ≥8 analysis when results were adjusted
for sex, energy intake, MDS, and physical activity; p = 0.132) (Table 3). The nut consumption median
for unmet ≥6 and ≥8 DRIs was 8.0 (IQR: 4.0, 14.6) in both cases; and for unmet <6 and <8 DRIs was
12.6 g/day in both cases (IQR: 6.0, 27.4 and 6.0, 25.2, respectively) (Table 4).
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Table 1. Lifestyle and dietary characteristics according to nut consumption.
Non-Nut Consumers (n = 1091) Nut Consumers (n = 4969) p
Mean (SD) Median (IQR) Mean (SD) Median (IQR)
Subject characteristics
Age (years) † 65.2 (4.9) 65.0 (61.0, 69.0) 65.0 (4.9) 65.0 (61.0, 69.0) 0.222
Body mass index (kg/m2) 33.2 (3.5) 32.9 (30.4, 35.8) 32.6 (3.4) 32.2 (29.9, 34.9) <0.001
Total physical activity (MET·min/week) *,† 2074 (1845) 1573 (707, 3019) 2487 (1952) 2014 (1007, 3476) <0.001
Males † 2402 (2079) 1958 (888, 3357) 2837 (2174) 2294 (1147, 4091) <0.001
Females † 1780 (1552) 1386 (559, 2587) 2093 (1577) 1734 (839, 2946) <0.001
Smoking habit ‡
Current smoker 173 (16.2) 567 (11.7) <0.001
Former smoker 432 (40.4) 2128 (43.8)
Never smoked 463 (43.4) 2167 (44.6)
Nutrients
Energy intake (kcal/day) † 2141 (555) 2096 (1729, 2495) 2360 (518) 2333 (1996, 2692) <0.001
Carbohydrate intake (% total energy) 42.3 (7.6) 42.2 (37.3, 47.6) 40.5 (6.6) 40.5 (35.9, 45.0) <0.001
Solid carbohydrate (g/day) 200.6 (69.1) 191.0 (152.1, 243.0) 214.6 (64.9) 209.6 (166.3, 254.5) <0.001
Liquid carbohydrate (g/day) 8.6 (13.8) 1.6 (0.0, 11.4) 8.9 (12.4) 3.3 (0.0, 12.3) 0.641
Glycemic index 53.7 (5.6) 54.1 (50.5, 57.7) 53.3 (5.1) 53.7 (50.1, 57.0) 0.015
Protein intake (% total energy) 16.8 (3.1) 16.6 (14.7, 18.6) 16.5 (2.7) 16.3 (14.6, 18.1) 0.002
Fat intake (% total energy) 37.6 (7.1) 37.2 (32.7, 42.3) 39.9 (6.3) 39.9 (35.5, 44.2) <0.001
PUFA (% total energy) 5.1 (1.3) 5.0 (4.3, 5.7) 6.6 (1.7) 6.3 (5.3, 7.5) <0.001
MUFA (% total energy) 19.3 (4.7) 19.0 (15.8, 22.4) 20.9 (4.5) 20.7 (17.6, 23.8) <0.001
SFA (% total energy) 9.9 (2.2) 9.8 (8.5, 11.3) 9.9 (1.9) 9.8 (8.6, 11.1) 0.543
Trans fatty acid (g/d) 0.6 (0.4) 0.5 (0.3, 0.7) 0.6 (0.4) 0.5 (0.3, 0.8) 0.901
Cholesterol (mg/d) 352.9 (114.5) 341.2 (278.9, 422.1) 374.9 (106.7) 365.8 (304.1, 433.4) <0.001
Fibre intake (g/d) 21.9 (7.4) 21.2 (16.8, 26.3) 25.9 (7.8) 24.8 (20.3, 30.4) <0.001
Food groups
Fruits (g/day) † 309.4 (189.9) 281.3 (175.2, 414.1) 352.5 (186.2) 326.6 (217.6, 456.2) <0.001
Vegetables (g/day) † 291.7 (129.6) 269.8 (202.1, 365.5) 322.0 (128.8) 304.4 (230.2, 398.1) <0.001
Legumes (g/day) † 18.9 (11.2) 16.4 (12.1, 24.8) 20.3 (10.1) 16.8 (16.1, 24.8) <0.001
Olive oil (g/day) † 38.0 (17.5) 35.0 (25.0, 50.0) 40.4 (16.8) 50.0 (25.0, 50.0) <0.001
Nuts (g/day) † 0.0 (0.0) 0.0 (0.0, 0.0) 17.1 (15.8) 12.6 (6.0, 25.2) <0.001
Total fish (g/day) † 89.1 (44.4) 84.6 (56.6, 119.0) 101.0 (44.2) 96.1 (68.1, 128.6) <0.001
Total cereals (g/day) † 144.6 (80.1) 114.9 (87.4, 202.0) 148.1 (74.4) 122.1 (91.8, 204.3) 0.182
Dairy products (g/day) † 346.7 (195.0) 306.9 (220.6, 518.7) 331.3 (182.3) 298.0 (216.6, 418.1) 0.017
Total meat (g/day) † 138.9 (58.3) 134.1 (101.6, 171.9) 144.9 (54.6) 139.6 (109.2, 177.2) 0.002
Cookies (g/day) † 26.5 (31.3) 14.6 (4.2, 39.4) 26.6 (29.1) 17.4 (6.7, 37.8) 0.938
Alcohol (g/day) † 10.9 (16.0) 4.3 (0.0, 12.9) 11.0 (14.8) 5.0 (0.7, 14.7) 0.826
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Table 1. Cont.
Non-Nut Consumers (n = 1091) Nut Consumers (n = 4969) p
Mean (SD) Median (IQR) Mean (SD) Median (IQR)
Diet Quality Measures (units)
17-item MDS † 7.7 (2.6) 8.0 (6.0, 10.0) 8.6 (2.6) 9.0 (7.0, 10.0) <0.001
CQI † 11.1 (3.4) 11.0 (8.0, 14.0) 12.1 (3.4) 12.0 (9.0, 15.0) <0.001
FQI † 2.5 (0.6) 2.4 (2.1, 2.8) 2.8 (0.6) 2.7 (2.3, 3.1) <0.001
MetS components: n (%)
High blood pressure ‡ 1012 (92.8) 4577 (92.1) 0.469
Hyperglycemia ‡ 839 (76.9) 3738 (75.2) 0.244
Hypertriglyceridemia ‡ 613 (56.2) 2781 (56.0) 0.895
Low HDL-cholesterol ‡ 459 (42.1) 2130 (42.9) 0.631
Abdominal obesity ‡ 1053 (96.5) 4771 (96.0) 0.438
Males ‡ 476 (93.0) 2424 (93.0) 0.969
Females ‡ 577 (99.7) 2347 (99.3) 0.490
Abbreviations: MDS, Mediterranean diet score; CQI, carbohydrates quality index; FQI, fat quality index; HDL-cholesterol, high density lipoprotein cholesterol; MET, metabolic equivalent
of task. * Participants who not responded the physical activity questionnaires and participants reporting outliers for total physical activity expressed as MET·min/week (at 3 or more
standard deviations from the mean) were excluded from the analysis (i.e., 79 participants ‘non-nut consumers’ and 239 participants ‘nut consumers’). † Difference in means between
non-nut consumers and nut consumers were tested by unpaired Students’ t-test. ‡ The difference in prevalence across the two comparison groups was examined using χ2.
Table 2. Usual intake and percentage of population below the estimated average requirement (EAR) or above adequate intake (AI) in nut-consumers (n = 4969)
compared with non-nut consumers (n = 1091).
Usual Intake Percentile EAR % Below EAR
Variable Group Mean (SD) P 1 10 25 50 75 90 % P 2
Vitamin A RAE (µg/day) Non-nutconsumers 940.6 (517.0) <0.001 439.7 564.9 783.6 1171.9 1692.4 M: 625.0 µg/day 23.9 <0.001
Nut-consumers 1064.0 (533.6) 521.2 662.6 913.2 1387.2 1826.7 W: 500.0 µg/day 15.1
Vitamin B1 (mg/day) Non-nutconsumers 1.4 (0.4) <0.001 1.0 1.2 1.4 1.7 1.9 M: 1.0 mg/day 8.7 <0.001
Nut-consumers 1.6 (0.4) 1.2 1.4 1.6 1.8 2.1 W: 0.9 mg/day 2.5
Vitamin B2 (mg/day) Non-nutconsumers 1.8 (0.5) <0.001 1.2 1.4 1.7 2.1 2.5 M: 1.1 mg/day 4.5 <0.001
Nut-consumers 1.9 (0.5) 1.3 1.6 1.9 2.3 2.6 W: 0.9 mg/day 2.0
Vitamin B3 NE (mg/day) Non-nutconsumers 36.3 (9.1) <0.001 25.2 30.1 35.6 42.3 48.0 M: 12.0 mg/day 0.0 1.000
Nut-consumers 39.8 (8.8) 28.8 33.7 39.6 45.7 51.4 W: 11.0 mg/day 0.0
Vitamin B6 (mg/day) Non-nutconsumers 2.0 (0.5) <0.001 1.4 1.7 2.0 2.4 2.7 M: 1.4 mg/day 6.2 <0.001
Nut-consumers 2.3 (0.5) 1.7 1.9 2.3 2.6 3.0 W: 1.3 mg/day 2.6
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Table 2. Cont.
Usual Intake Percentile EAR % Below EAR
Variable Group Mean (SD) P 1 10 25 50 75 90 % P 2
Vitamin B12 (µg/day) Non-nutconsumers 8.7 (3.8) <0.001 4.5 5.9 8.0 10.9 14.1 M: 2.0 µg/day 0.4 0.088
Nut-consumers 9.7 (3.8) 5.3 6.7 9.0 12.0 15.1 W: 2.0 µg/day 0.1
Folic acid (µg/day) Non-nutconsumers 303.7 (86.7) <0.001 200.2 242.0 295.0 354.3 419.1 M: 320.0 µg/day 60.6 <0.001
Nut-consumers 345.8 (89.4) 238.8 283.0 335.5 400.9 470.2 W: 320.0 µg/day 42.5
Vitamin C (mg/day) Non-nutconsumers 175.0 (74.6) <0.001 85.5 120.8 165.6 217.3 277.3 M: 75.0 mg/day 4.6 <0.001
Nut-consumers 197.5 (76.6) 108.4 142.5 184.4 243.5 304.0 W: 60.0 mg/day 1.9
Vitamin D (µg/day) Non-nutconsumers 5.2 (3.2) <0.001 1.9 3.0 4.3 6.8 10.2 M: 10.0 µg/day 89.6 0.001
Nut-consumers 6.1 (3.2) 2.6 3.8 5.1 8.8 10.8 W: 10.0 µg/day 85.7
Vitamin E (mg/day) Non-nutconsumers 8.3 (2.7) <0.001 5.3 6.5 7.9 9.5 11.5 M: 12 mg/day 91.8 <0.001
Nut-consumers 10.6 (3.2) 6.9 8.3 10.0 12.3 15.0 W: 12 mg/day 71.9
Ca (mg/day) Non-nutconsumers 950.9 (325.3) <0.001 572.5 708.8 909.9 1144.1 1391.5
M 51–70 y-o: 800.0 mg/day
M >70 y-o: 1000.0 mg/day
W: 1000.0 mg/day
50.6 <0.001
Nut-consumers 1008.4 (306.1) 637.7 789.4 977.0 1208.7 1418.4 40.2
Mg (mg/day) Non-nutconsumers 344.4 (86.2) <0.001 245.4 284.7 331.1 393.7 461.7 M: 350.0 mg/day 36.7 <0.001
Nut-consumers 402.9 (94.5) 288.9 333.8 394.8 463.2 533.8 W: 265.0 mg/day 18.8
P (mg/day) Non-nutconsumers 1580.8 (388.3) <0.001 1109.0 1291.8 1541.2 1827.1 2099.9 M: 580.0 mg/day 0.2 0.086
Nut-consumers 1728.7 (374.9) 1253.3 1465.5 1714.3 1985.1 2225.5 W: 580.0 mg/day 0.0
Fe (mg/day) Non-nutconsumers 14.6 (3.6) <0.001 10.2 12.1 14.3 16.8 19.5 M: 6.0 mg/day 0.2 0.086
Nut-consumers 16.4 (3.6) 12.0 13.9 16.2 18.8 21.3 W: 5.0 mg/day 0.0
Se (µg/day) Non-nutconsumers 106.1 (32.1) <0.001 66.9 83.1 102.7 126.8 148.8 M: 45.0 µg/day 1.4 <0.001
Nut-consumers 116.5 (30.5) 78.7 94.8 114.9 136.1 157.0 W: 45.0 µg/day 0.3
Zn (mg/day) Non-nutconsumers 12.0 (3.1) <0.001 8.4 9.8 11.7 13.9 16.3 M: 9.4 mg/day 9.4 <0.001
Nut-consumers 13.1 (3.0) 9.4 11.0 12.9 15.0 17.1 W: 6.8 mg/day 5.0
Iodine (µg/day) Non-nutconsumers 282.5 (153.8) 0.213 92.9 176.4 252.2 328.0 531.0 M: 95.0 µg/day 10.4 0.577
Nut-consumers 276.1 (143.5) 95.5 181.5 258.2 298.2 531.9 W: 95.0 µg/day 9.8
K (g/day) Non-nutconsumers 4.0 (1.0) <0.001 2.9 3.3 3.9 4.6 5.4 M: 4.7 g/day 23.5 <0.001
Nut-consumers 4.4 (1.0) 3.3 3.8 4.4 5.1 5.7 W: 4.7 g/day 37.7
Cr (µg/day) Non-nutconsumers 76.7 (46.1) <0.001 37.4 46.7 61.4 89.7 140.1 M: 30.0 µg/day 98.8 0.046
Nut-consumers 83.8 (44.2) 42.1 51.8 70.6 103.7 144.5 W: 20.0 µg/day 99.4
Abbreviations: EAR, estimated average requirement; AI, adequate intake; SD, standard deviation; RAE, retinol activity equivalents; NE, niacin equivalents; vitamin E (i.e., α-tocopherol);
M: men; W: women; Ca, calcium; Mg, magnesium; P, phosphorous; Fe, iron; Se, selenium; Zn, zinc; K, potassium; Cr, chromium; y-o: years-old. 1 Difference in means between non-nut
consumers and nut consumers were tested by unpaired Students’ t-test. 2 The difference in prevalence across the two comparison groups was examined using χ2.
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Table 3. Usual intake of vitamins and minerals of the nut consumers (n = 4969).
Quintiles of Nut Consumption
Variables Q1 (n = 1182) Q2 (n = 980) Q3 (n = 848) Q4 (n = 987) Q5 (n = 972) p *
Vitamin A RAE (µg/day)
Mean ± SD 980.5 ± 520.2 a,b,c,d 1055.1 ± 519.9 a,g 1069.9 ± 532.6 b,h,i 1096.2 ± 525.9 c 1136.8 ± 558.2 d,h,i <0.001
% below EAR 20.8 13.2 14.6 13.3 12.1 <0.001
Vitamin B1 (mg/day)
Mean ± SD 1.5 ± 0.4 a,b,c,d 1.6 ± 0.4 a,f,g 1.6 ± 0.4 b,h,i 1.7 ± 0.3 c,f,h,j 1.8 ± 0.3 d,g,i,j <0.001
% below EAR 4.7 2.9 2.5 1.3 0.4 <0.001
Vitamin B2 (mg/day)
Mean ± SD 1.8 ± 0.5 b,c,d 1.9 ± 0.5 f,g 1.9 ± 0.5 b,h,i 2.0 ± 0.5 c,f,h,j 2.1 ± 0.5 d,g,i,j <0.001
% below EAR 3.2 1.9 2.0 1.2 1.4 0.009
Vitamin B3 NE (mg/day)
Mean ± SD 37.8 ± 8.8 a,b,c,d 39.3 ± 8.7 a,f,g 39.3 ± 8.6 b,h,i 41.0 ± 8.6 c,f,h 42.1 ± 8.6 d,g,i <0.001
% below EAR 0.0 0.0 0.0 0.0 0.0 1.000
Vitamin B6 (mg/day)
Mean ± SD 2.1 ± 0.5 a,b,c,d 2.2 ± 0.5 a,f,g 2.3 ± 0.5 b,h,i 2.4 ± 0.5 c,f,h,j 2.5 ± 0.5 d,g,i,j <0.001
% below EAR 6.6 2.6 1.8 1.0 0.3 <0.001
Vitamin B12 (µg/day)
Mean ± SD 9.2 ± 3.8 a,c,d 9.7 ± 3.8 a 9.6 ± 3.8 10.0 ± 3.9 c 10.0 ± 3.9 d <0.001
% below EAR 0.1 0.1 0.2 0.2 0.0 0.590
Folic acid (µg/day)
Mean ± SD 316.6 ± 83.9 a,b,c,d 332.1 ± 87.5 a,f,g 340.5 ± 82.4 b,h,i 358.3 ± 86.7 c,f,h,j 387.1 ± 89.1 d,g,i,j <0.001
% below EAR 57.3 48.1 45.4 35.1 24.2 <0.001
Vitamin C (mg/day)
Mean ± SD 181.5 ± 75.5 a,b,c,d 194.3 ± 77.2 a,g 195.2 ± 73.1 b,i 202.6 ± 74.4 c,j 216.9 ± 78.1 d,g,i,j <0.001
% below EAR 3.8 1.4 1.9 1.2 0.9 <0.001
Vitamin D (µg/day)
Mean ± SD 5.5 ± 3.1 a,b,c,d 6.0 ± 3.1 a,f,g 5.9 ± 3.1 b,h,i 6.5 ± 3.3 c,f,h 6.6 ± 3.3 d,g,i <0.001
% below EAR 89.1 87.6 88.1 82.1 81.1 <0.001
Vitamin E (mg/day)
Mean ± SD 8.9 ± 2.7 a,b,c,d 9.9 ± 2.5 a,f,g 10.0 ± 2.6 b,h,i 11.4 ± 2.7 c,f,h,j 13.1 ± 3.7 d,g,i,j <0.001
% below EAR 89.0 84.8 80.8 62.5 39.7 <0.001
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Table 3. Cont.
Quintiles of Nut Consumption
Variables Q1 (n = 1182) Q2 (n = 980) Q3 (n = 848) Q4 (n = 987) Q5 (n = 972) p *
Ca (mg/day)
Mean ± SD 961.6 ± 296.8 b,c,d 983.4 ± 295.5 f,g 1000.4 ± 310.9 b,i 1027.3 ± 307.2 c,f,j 1078.6 ± 308.6 d,g,i,j <0.001
% below EAR 46.7 43.4 41.4 38.2 30.3 <0.001
Mg (mg/day)
Mean ± SD 355.7 ± 83.5 a,b,c,d 379.1 ± 84.6 a,e,f,g 392.5 ± 81.8 b,e,h,i 424.5 ± 87.0 c,f,h,j 471.7 ± 88.9 d,g,i,j <0.001
% below EAR 32.4 23.0 18.5 12.5 4.7 <0.001
P (mg/day)
Mean ± SD 1609.6 ± 358.8 a,b,c,d 1671.7 ± 358.8 a,f,g 1706.7 ± 360.7 b,h,i 1785.8 ± 367.9 c,f,h,j 1891.9 ± 361.9 d,g,i,j <0.001
% below EAR 0.1 0.0 0.0 0.0 0.0 0.524
Fe (mg/day)
Mean ± SD 15.2 ± 3.5 a,b,c,d 16.0 ± 3.5 a,f,g 16.2 ± 3.4 b,h,i 16.9 ± 3.4 c,f,h,j 18.0 ± 3.4 d,g,i,j <0.001
% below EAR 0.1 0.0 0.0 0.0 0.0 0.524
Se (µg/day)
Mean ± SD 111.3 ± 31.5 b,c,d 114.8 ± 29.8 f,g 115.6 ± 30.6 b,i 119.2 ± 29.7 c,f 122.7 ± 29.54 d,g,i <0.001
% below EAR 0.5 0.4 0.4 0.2 0.0 0.251
Zn (mg/day)
Mean ± SD 12.4 ± 3.0 a,b,c,d 12.8 ± 3.0 a,f,g 12.9 ± 3.0 b,h,i 13.4 ± 2.9 c,f,h,j 13.9 ± 2.8 d,g,i,j <0.001
% below EAR 7.4 5.3 5.4 4.4 1.9 <0.001
Iodine (µg/day)
Mean ± SD 280.7 ± 144.9 266.4 ± 135.5 279.4 ± 146.8 274.4 ± 145.1 279.3 ± 144.8 0.148
% below EAR 10.2 9.0 10.0 9.5 10.2 0.862
K (g/day)
Mean ± SD 4135.7 ± 927.2 a,b,c,d 4290.8 ± 923.2 a,e,f,g 4424.5 ± 891.3 b,e,h,i 4597.0 ± 957.3 c,f,h,j 4855.8 ± 954.2 d,g,i,j <0.001
% above AI 25.2 30.7 36.1 43.9 55.1 <0.001
Cr (µg/day)
Mean ± SD 77.4 ± 44.0 c,d 79.3 ± 41.8 f,g 82.7 ± 42.2 h,i 88.8 ± 45.3 c,f,h 92.2 ± 45.6 d,g,i <0.001
% above AI 98.7 99.6 99.4 99.5 99.8 0.020
Abbreviations: AI: adequate intake. EAR: estimated average requirements. Nut consumption range in each of the quintiles: Q1: <4.2 g/day, n = 911; Q2: 4.2–8.3 g/day, n = 1058;
Q3: 8.4–14.5 g/day, n = 868; Q4: 14.6–29.3 g/day, n = 1093; Q5: ≥29.4 g/day, n = 1039. * Differences in means between quintiles were tested by one-way ANOVA with Bonferroni’s post-hoc
test. Different letters indicate statistically significant differences between quintile groups.
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the quintiles: Q1: <4.2 g/day, n = 911; Q2: 4.2–8.3 g/day, n = 1058; Q3: 8.4–14.5 g/day, n = 868; Q4: 14.6–
29.3, n = 1093; Q5: ≥29.4 g/day, n = 1039. DRI, dietary reference intake; Q, quintile. Differences in 
means between quintiles were tested by one-way ANOVA (p < 0.001) with Bonferroni’s post-hoc test. 
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Table 4. Unmet dietary reference intakes (DRI) ≥6 and ≥8 number of nutrients in nut-consumers (n = 
4969) compared with non-nut consumers as reference value (n = 1091). 
Unmet DRI Non-Nut Consumers 
(n = 1091) 
Nut Consumers 
(n = 4969) 
P 1 
Failing to meet 6 or more recommendations 
<6 64.4 80.6 <0.001 
≥6 35.6 19.4  
Crude OR 2 (95% CI) 1.00 (ref.) 0.44 (0.38, 0.50) **  
Adjusted OR 3 (95% CI) 1.00 (ref.) 0.58 (0.49, 0.69) **  
Adjusted OR 4 (95% CI) 1.00 (ref.) 0.59 (0.49, 0.71) **  
Failing to meet 8 or more recommendations 
<8 89.2 95.0 <0.001 
≥8 10.8 5.0  
Figure 1. Mean (with standard deviation (SD)) number of nutrients with intakes not meeting the
recommended levels across quintiles of nut consumption (g/day). Nut consumption range in each
of the quintiles: Q1: <4.2 g/day, n = 911; Q2: 4.2–8.3 g/day, n = 1058; Q3: 8.4–14.5 g/day, n = 868;
Q4: 14.6–29.3, n = 1093; Q5: ≥29.4 g/day, n = 1039. DRI, dietary reference intake; Q, quintile. Differences
in means between quintiles were tested by one-way ANOVA (p < 0.001) with Bonferroni’s post-hoc test.
Different letters indicate statistically significant differences between quintile groups.
Table 4. Unmet dietary reference intakes (DRI) ≥6 and ≥8 number of nutrients in nut-consumers
(n = 4969) compared with non-nut consumers as reference value (n = 1091).
Unmet DRI Non-Nut Consumers (n = 1091) Nut Consumers (n = 4969) p 1
Failing to meet 6 or more recommendations
<6 64.4 80.6 <0.001
≥6 35.6 19.4
Crude OR 2 (95% CI) 1.00 (ref.) 0.44 (0.38, 0.50) **
Adjusted OR 3 (95% CI) 1.00 (ref.) 0.58 (0.49, 0.69) **
Adjusted OR 4 (95% CI) 1.00 (ref.) 0.59 (0.49, 0.71) **
Failing to meet 8 or more recommendations
<8 89.2 95.0 <0.001
≥8 10.8 5.0
Crude OR 2 (95% CI) 1.00 (ref.) 0.43 (0.34, 0.54) **
Adjusted OR 3 (95% CI) 1.00 (ref.) 0.73 (0.55, 0.97) *
Adjusted OR 4 (95% CI) 1.00 (ref.) 0.80 (0.59, 1.07) NS
Abbreviations: OR, odds ratio; CI, confidence interval; ref., reference. Values are expressed as n (%) and OR (95% CI).
1 Significant differences in prevalence were calculated by means of χ2. 2 Logistic regression analysis comparing the
two different cut-offs (independent variables) between nut-consumers and non-nut consumers as reference value
(dependent variable). 3 Logistic regression analysis after adjustment for sex, energy intake (continuous variable)
and total physical activity (continuous variable, expressed as MET·min/week). 4 Logistic regression analysis
after additional adjustment for total fat intake (continuous variable, expressed as % of total energy intake), and
Mediterranean diet score (MDS) (continuous variable). 3,4 Participants who not responded the physical activity
questionnaires and participants reporting outliers for total physical activity expressed as MET·min/week (at 3 or
more standard deviations from the mean) were excluded from the analysis (i.e., 79 participants ‘non-nut consumers’
and 239 participants ‘nut consumers’). * p <0.05; ** p <0.001; NS: no significant.
4. Discussion
In the present study nutrient adequacy and diet quality was better in nut consumers than in
non-consumers. This study also confirmed that nut consumption was associated with better adherence
to the MedDiet (MDS) than that observed in their non-consumers counterparts. Furthermore, nut
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consumers had lower BMI [26], were more likely to be physically active and less likely to smoke
than non-nut consumers. A novelty of the present study is that it investigated these associations in a
Mediterranean population at high cardiovascular risk. Moreover, nut consumers (82%) were higher
in this study than in previous reports, such as the NHANES 2005–2010 (n = 14386; nut consumers:
5.2%) [4], the NHANES 2001–2010 (n = 24,808; almond consumers: 1.6%) [5] and the NZANS 2008/09
(n = 4721; nut consumers: 28.9%) [6]; however, the median of nut consumption was only 12.6 g/day
(IQR: 6.0, 25.2).
This study showed that nut consumers were less likely to be below the EAR for some
nutrients and above the AI for others than non-nut consumers. Moreover, higher nut consumers
showed better compliance with the nutritional recommendations for micronutrients. Previously,
Roman–Viñas et al. [27] analyzed the prevalence of inadequate intakes of several micronutrients
(vitamins B12, C, and D; folic acid, Ca, Fe, Se, iodine and Cu) in European adult (19–64 years) and elderly
(>64 years) populations. In their study, Roman–Viñas et al. [27] showed a prevalence of inadequacy
equal or below 10% for Zn, Fe, and vitamin B12 (only in the elderly population); prevalence between
11–20% for Cu in the adult and elderly populations, for vitamin B12 in the adult population, and for
vitamin C in the elderly Europeans; and a prevalence above 21% for vitamin D, vitamin C (only in the
adult population), folic acid, Ca, Se, and iodine [27]. Nevertheless, to our knowledge, only two studies
conducted by O’Neil et al. [4,5] using NHANES data have previously examined associations between
nut consumption and nutrient adequacy.
O’Neil et al. [4] analyzing data from the NHANES 2005–2010 found a lower prevalence of
inadequacy for vitamins A, C and E, folate, Ca, Mg, Fe, Zn and K in nut-consumers than in non-nut
consumers. Lately, O’Neil et al. [5] also examined the prevalence of inadequate intakes of a number
of micronutrients between almond and non-almond consumers from the NHANES 2001–2010 and
found a lower prevalence of inadequacy for vitamins A, B2, C and E, Ca, Mg, P, Zn and Cu in almond
consumers than in non-almond consumers [5]. Accordingly, in our study the prevalence of inadequate
intakes of vitamins A, B1, B2, B6, C, D and E, folate, Ca, Mg, Se and Zn were lower in nut consumers
than in non-nut consumers.
Nuts are rich in vitamin E, folate, Ca and Mg, and in our study the proportions of inadequate
intakes for these four micronutrients were high, especially in non-nut consumers, in which the
proportions with intakes below the EAR were 37–92%, in comparison with nut consumers, in which
the proportions were 20–72%. Accordingly, O’Neil et al. [6] also found a high proportion of non-nut
consumers with intakes below the EAR for vitamin E, Ca and Mg (i.e., 94.2%, 44.3% and 60.1%,
respectively) in comparison with nut consumers (37.7%, 26.9% and 8.2%, respectively). Previously,
Serra-Majem et al. [28], assessing the relationship between nutrient adequacy and a posteriori defined
Mediterranean and Western dietary pattern in the Seguimiento Universidad de Navarra (SUN) cohort,
also found that 89–94% of participants did not comply with recommended vitamin E intakes. Moreover,
the proportions of inadequate intakes for folic acid and Mg were also higher in the first quintile of
adherence to the Mediterranean dietary pattern (19% and 21%, respectively) than in the fifth quintile
(10% and 2%, respectively) [27]. Recently, Zazpe et al. [2] also found an inverse association between
the risk of failing to meet ≥4 DRIs and deciles of adherence to the MedDiet (Mediterranean diet score,
MDS) in participants of the SUN cohort.
Most species of nuts have high contents of K (e.g., almonds, pine nuts, pecans). While
O’Neil et al. [4,5] studies found a proportion of inadequate intake for K below 12% in both nut
and non-nut consumers, in our study the prevalence of inadequacy for K was above 21% in both
groups. However, K intake is still below the recommended intakes in our population [17]. Moreover,
not only nuts but also fruits, vegetables and dairy products, which were more frequently consumed by
nut consumers than non-nut consumers, are high K foods.
Nuts are poor sources of vitamin D. However, in Mediterranean countries, it can be obtained
from conversion through the skin stimulated by UV radiation. Therefore, the proportion that should
be obtained from food is unknown [1,29]. According to O’Neil’s studies [4,5], its prevalence of
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inadequacy was also exceptionally very high in both groups (i.e., 86% in nut consumers and 90% in
non-nut consumers).
Finally, nut consumers had lower prevalence of inadequate micronutrient intakes (≥6 and
≥8 DRI), but also higher CQI, adherence to the MedDiet (Mediterranean diet score, MDS) and FQI
than non-nut consumers. In this line, Sánchez–Tainta et al. [2] have also recently reported lower
prevalence of inadequate micronutrient intakes (≥8 DRI) in the highest quintile of CQI or adherence
to the MedDiet (Mediterranean Diet Score, MDS), and in the lowest quintile of FQI. Nevertheless, in
Spain there is a general thought that nuts can decrease the cardiovascular risk, and nut consumers
may also be more conscious of having a MedDiet. Nevertheless, the median consumption of nuts
for which the DRIs were unmet <6 and <8 was only 12.6 g/day in both cases (IQR: 6.0, 27.4 and 6.0,
25.2, respectively).
5. Strengths and Limitations of the Study
The strengths of this study are that it used a large Mediterranean sample at high cardiovascular
risk and that, the contribution of supplements to micronutrient intake was considered. The main
limitation of this study is that it is a cross-sectional study; thus, we fully acknowledge that causal
inferences cannot be drawn but only observations. A second limitation is that all nutritional data
presented here is self-reported, as well as most of nutritional assessment methods. Another limitation is
that the same source of information was used to assess nut intake and nutritional adequacy. Moreover,
the self-reported FFQ could overestimate the intake of certain food groups even having been validated.
Nevertheless, it is likely to be similar in both compared groups and therefore could only contribute
to the increase of the measurement error and to dilute the true differences. Furthermore, in order
address such a possible error and avoid information bias we excluded participants with energy or
micronutrient intake out of predefined ranges [2]. Previously, in the PREDIMED study, 827 participants
who had extreme values for total energy intake or any micronutrient intake out of the predefined
values were also excluded in the nutritional adequacy analysis [2]. Nonetheless, plasma concentrations
of vitamins and micronutrients were not determined in our study. Finally, nut consumers may simply
be more health conscious than non-nut consumers [6]. Nevertheless, this is a cross-sectional study and
therefore we acknowledge that we are not able to draw causal conclusions but only observations.
6. Conclusions
In conclusion, a high proportion of individuals at high cardiovascular risk consumed nuts.
The rate was higher than in previous similar studies; however, the average amount of daily nut
consumption was low among them. Nevertheless, consumption of nuts was associated with nutrient
adequacy, better diet quality, and higher adherence to the MedDiet (Mediterranean diet score, MDS)
than those seen in non-nut consumers. Nuts contributed to these results and to an overall healthier
diet. Thus, consumption of nuts should be encouraged by health professionals, including registered
dietitians. Moreover, nutrition education programs that increase awareness, health benefits, and
consumption of nuts should be designed for the general adult population at high cardiovascular risk
to attain nutrient adequacy. This study also raises the possibility that future research should include a
categorized nut consumption amount to assess health benefits in interventional programs encouraging
nut consumption.
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AI Adequate intake
CHO Carbohydrate
CQI Carbohydrate quality index
EAR Estimated average requirements
erMedDiet Energy-restricted traditional MedDiet
FFQ Food frequency questionnaire
FQI Fat quality index
MedDiet Mediterranean diet
MET Metabolic equivalents
MetS Metabolic syndrome
NHANES National Health and Nutrition Examination Survey
NE Niacin equivalents
NZANS New Zealand Adult Nutrition Survey
RAE Retinol activity equivalents
RAPA Rapid assessment of physical activity questionnaire
RDA Recommended daily allowances
DRI Dietary reference intake
TFA Trans fatty acid
UL Tolerable upper level
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